Skip to main content
News Directory 3
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Medicare Kidney Failure Trial Ends Early - News Directory 3

Medicare Kidney Failure Trial Ends Early

December 2, 2025 Jennifer Chen Health
News Context
At a glance
  • The Centers for Medicare and Medicaid Services (CMS) will cut short its End-Stage Renal Disease Treatment Choices (ETC) model, a significant experiment designed to reshape dialysis care in...
  • Launched by the CMS Innovation Center, the ETC model aimed to incentivize providers to increase the number of patients receiving dialysis at home and undergoing kidney transplantation.
  • Despite its scale, the ETC model did not achieve its intended outcomes.
Original source: statnews.com

“`html





CMS Ends Landmark Dialysis Experiment – ETC Model


CMS Ends Landmark Dialysis Experiment – ETC Model

Table of Contents

  • CMS Ends Landmark Dialysis Experiment – ETC Model
    • At a Glance
    • What Happened: The End of the ETC Model
    • Why the ETC Model Failed: Lack of Impact on Key Metrics
      • Barriers to Home Dialysis Adoption

At a Glance

  • What: the Centers for Medicare & Medicaid Services (CMS) is terminating the End-Stage Renal Disease Treatment Choices (ETC) model.
  • Where: United States (involved 30% of dialysis providers).
  • When: The model will officially end on December 31, 2025.
  • Why it Matters: The ETC model was the largest experiment of its kind, aiming to shift dialysis towards home-based treatments and increase kidney transplantation rates. Its failure raises questions about the effectiveness of financial incentives in driving these changes.
  • What’s Next: CMS will likely re-evaluate strategies for improving kidney care and increasing access to home dialysis and transplantation. Further research and option payment models may be explored.

What Happened: The End of the ETC Model

The Centers for Medicare and Medicaid Services (CMS) will cut short its End-Stage Renal Disease Treatment Choices (ETC) model, a significant experiment designed to reshape dialysis care in the U.S. The agency, led by Mehmet Oz, announced the termination in a final rule published in the Federal Register last week.

Launched by the CMS Innovation Center, the ETC model aimed to incentivize providers to increase the number of patients receiving dialysis at home and undergoing kidney transplantation. It was the largest such experiment in the history of American health care, requiring participation from 30% of the nation’s dialysis providers.

Why the ETC Model Failed: Lack of Impact on Key Metrics

Despite its scale, the ETC model did not achieve its intended outcomes. Initial analysis following the first year, 2021, revealed no discernible impact on rates of home dialysis or kidney transplantation. A subsequent study conducted last summer corroborated these findings.

The study found that providers participating in the new payment model weren’t getting more patients onto home dialysis or to transplant than those in the control group. This suggests that the financial incentives offered by the ETC model were insufficient to overcome existing barriers to these treatment options.

Barriers to Home Dialysis Adoption

  • Patient Suitability: Not all patients are medically suitable for home dialysis due to health conditions or lifestyle factors.

    Share this:

    • Share on Facebook (Opens in new window) Facebook
    • Share on X (Opens in new window) X

    Related

Medicaid, Medicare, Research, STAT+

Search:

News Directory 3

ByoDirectory is a comprehensive directory of businesses and services across the United States. Find what you need, when you need it.

Quick Links

  • Disclaimer
  • Terms and Conditions
  • About Us
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Editorial Guidelines
  • Privacy Policy

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

Connect With Us

© 2026 News Directory 3. All rights reserved.

Privacy Policy Terms of Service